ADVFN US – Market Content Editor
-
GameStop shares climb after unveiling performance-linked pay plan for CEO Cohen
Shares of GameStop Corp (NYSE:GME) rose about 3.6% in premarket trading on Wednesday after the company disclosed a new compensation structure for Chairman and Chief Executive Officer Ryan Cohen, tying his pay entirely to ambitious growth and profitability targets. The video game retailer said Cohen’s compensation is “100% at-risk,” with no fixed salary, cash bonuses…
-
Innovative Eyewear shares surge on strong Q4 sales growth and insider buying plans
Shares of Innovative Eyewear Inc (NASDAQ:LUCY) jumped about 38% in premarket trading on Wednesday after the company reported a sharp increase in fourth-quarter sales, with preliminary figures pointing to year-on-year growth of roughly 45%. The smart eyewear manufacturer, which designs products under brands such as Lucyd, Reebok and Nautica, said revenue for the fourth quarter…
-
Hyperscale Data shares jump after publishing preliminary asset valuations
Shares of Hyperscale Data, Inc. (AMEX:GPUS) climbed about 14% in premarket trading on Wednesday after the company released early estimates of its total assets and net asset value per share as of December 31, 2025. The AI-focused data center operator, which describes itself as an “AI data center company anchored by Bitcoin,” said it estimates…
-
Curis shares jump after lining up up to $80.8m in private placement financing
Shares of Curis Inc (NASDAQ:CRIS) surged around 19% in premarket trading on Wednesday after the biotech group said it has entered into a private placement that could raise gross proceeds of up to $80.8 million. The financing, backed by healthcare-focused institutional investors alongside company insiders, is expected to generate initial gross proceeds of roughly $20.2…
-
Micron to launch construction of $100bn New York semiconductor megafab
Micron Technology Inc. (NASDAQ:MU) said it will officially break ground on January 16, 2026, for its new semiconductor manufacturing complex in Onondaga County, New York, marking a $100 billion investment that the company describes as the largest private project ever undertaken in the state. The site is expected to eventually accommodate up to four fabrication…
-
Salarius shares jump after rebranding announcement to Decoy Therapeutics
Shares of Salarius Pharmaceuticals Inc (NASDAQ:SLRX) climbed 11.7% in premarket trading on Wednesday after the company said it will rebrand as Decoy Therapeutics Inc. and begin trading under the new ticker symbol “DCOY” from January 8, 2026. The Cambridge, Massachusetts–based group said the name change underscores a strategic pivot toward the development of peptide-conjugate therapeutics,…
-
Cardio Diagnostics shares jump after announcing first international expansion into India
Shares of Cardio Diagnostics Holdings Inc (NASDAQ:CDIO) climbed about 9.3% in premarket trading on Wednesday after the company unveiled plans to expand into India, marking its first move beyond the U.S. market. The AI-enabled cardiovascular diagnostics specialist said it has entered into a strategic partnership to introduce its PrecisionCHD blood test in India. The collaboration…
-
HUTCHMED shares edge higher after Phase III success for sovleplenib in wAIHA
Shares of HUTCHMED (NASDAQ:HCM) rose around 1.9% in premarket trading on Wednesday after the company reported positive Phase III results for sovleplenib in patients with warm antibody autoimmune hemolytic anemia (wAIHA). The company said its pivotal ESLIM-02 study met the primary endpoint, with sovleplenib — a next-generation spleen tyrosine kinase (SYK) inhibitor — delivering a…
-
Kamada shares climb after upbeat 2026 outlook points to double-digit growth
Shares of Kamada Ltd. (NASDAQ:KMDA) rose about 8% after the biopharmaceutical group released its financial guidance for 2026, forecasting another year of strong double-digit growth in both revenue and earnings. The Israel-based specialist in plasma-derived therapies said it expects 2026 revenue to reach between $200 million and $205 million, alongside adjusted EBITDA of $50 million…
-
Aspire Biopharma shares surge after FDA talks support heart attack drug pathway
Shares of Aspire Biopharma Holdings Inc (NASDAQ:ASBP) jumped more than 60% in premarket trading on Wednesday after the company said a pre-IND meeting with the Food and Drug Administration had produced positive feedback for its emergency heart attack treatment. Aspire said the FDA endorsed its proposed regulatory approach for OTASA, a sublingual aspirin powder intended…